Saturday, July 31, 2021 2:01:22 PM
We are going in circles you have been proven to be wrong so many times its getting tiresome. Again from the last 10K
We rely at present AS IN NOW on third-party contract manufacturerS PLURAL. As a result, we may be at risk for issues with manufacturing agreementS PLURAL, capacity limitations and/or supply disruptions, and/or issues with product equivalency.
We rely upon specialized contract manufacturerS PLURAL, operating in specialized GMP (clean room) manufacturing facilitieS PLURAL, to produce all of our DCVax products. We have worked with several such manufacturerS PLURAL, in several different locations (Swanston is last time I checked ONE location), during various periods of our clinical trials and our compassionate treatment programs, including Advent BioServices, Cognate BioServices and the Fraunhofer Institute.
Jeeez how well is your English?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=164355874
We rely at present AS IN NOW on third-party contract manufacturerS PLURAL. As a result, we may be at risk for issues with manufacturing agreementS PLURAL, capacity limitations and/or supply disruptions, and/or issues with product equivalency.
We rely upon specialized contract manufacturerS PLURAL, operating in specialized GMP (clean room) manufacturing facilitieS PLURAL, to produce all of our DCVax products. We have worked with several such manufacturerS PLURAL, in several different locations (Swanston is last time I checked ONE location), during various periods of our clinical trials and our compassionate treatment programs, including Advent BioServices, Cognate BioServices and the Fraunhofer Institute.
Jeeez how well is your English?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=164355874
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
